All community pharmacy articles
-
PHE/DH/DWP guidelinePHE influenza immunisation guideline
This Guidelines summary covers key points for administering influenza immunisation, and who should receive it.
-
NHS guideline
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
Independent professional body guideline
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
-
Independent professional body guideline
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
-
PHE/DH/DWP guideline
COVID-19 personal protective equipment (PPE)
This revised guidance concerns use of personal protective equipment (PPE) by health and social care workers, in the context of the current COVID-19 pandemic.
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema. Covers taking a clinical history, step-by-step treatment, and includes an eczema management plan.
-
PHE/DH/DWP guideline
PHE pneumococcal vaccination guideline (Green Book chapter 25)
A succinct summary of Public Health England’s Green Book chapter 25 pneumococcal vaccination programme
-
Independent professional body guideline
Recognition and management of sepsis in general practice
This Guidelines summary combines recommendations from The UK Sepsis Trust to give guidance on the recognition and management of sepsis in adults, children, and young people over 12 years of age
-
NICE guideline
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources
-
Independent professional body guideline
Recommended actions after incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch.
-
NICE guideline
COVID-19 rapid guideline: managing COVID-19 symptoms in the community
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
-
NICE guideline
NICE CKS—teething
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
-
NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
Independent professional body guideline
Consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update
This summary covers key recommendations for diagnosis and treatment of insomnia, parasomnia, and circadian rhythm disorders relevant to primary care.
-
NICE guideline
COVID-19 rapid guideline: pneumonia in adults
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.
-
NICE guideline
COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline ...
-
Independent professional body guideline
PCDS actinic keratosis guideline
This Guidelines summary includes recommendations on recognition and diagnosis of actinic keratosis, use of clinical findings, management and options for treatment. It includes an algorithm of the pathway from recognition to treatment in primary care, including red flags to recognise.
-
NICE guideline
NICE CKS candida—female genital
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.
-
PHE/DH/DWP guideline
PHE UK immunisation schedule (Green Book chapter 11)
What immunisations are needed, and when? What do you do if a patient’s immunisation status is incomplete or unknown?
